Intronic miR-3151 Within BAALC Drives Leukemogenesis by Deregulating the TP53 Pathway

Science Signaling - United States
doi 10.1126/scisignal.2004762
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Association for the Advancement of Science (AAAS)

Related search

BRAF Inactivation Drives Aneuploidy by Deregulating CRAF

Cancer Research
Cancer ResearchOncology
2010English

UV Radiation Drives Melanoma by Inducing TP53 Mutations

Cancer Discovery
Oncology
2014English

FTO-Mediated mRNA Demethylation Drives Leukemogenesis

Cancer Discovery
Oncology
2017English

Period2 Downregulation Inhibits Glioma Cell Apoptosis by Activating the MDM2-TP53 Pathway

Oncotarget
Oncology
2016English

Analysis of an Intronic Promoter Within Synj2

Biochemical and Biophysical Research Communications
BiochemistryCell BiologyMolecular BiologyBiophysics
2013English

ZEB1 Drives Prometastatic Actin Cytoskeletal Remodeling by Downregulating miR-34a Expression

Journal of Clinical Investigation
Medicine
2012English

Leukemogenesis by Ionizing Irradiation

Acta Radiologica
1954English

FLT3N676K Drives Acute Myeloid Leukemia in a Xenograft Model of KMT2A-MLLT3 Leukemogenesis

Leukemia
Cancer ResearchOncologyAnesthesiologyPain MedicineHematology
2019English

miR-1269b Drives Cisplatin Resistance of Human Non-Small Cell Lung Cancer via Modulating the PTEN/PI3K/AKT Signaling Pathway

OncoTargets and Therapy
OncologyPharmacology
2020English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy